VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma.
Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma. Front Oncol. 2022; 12:1022496.
View in:
PubMed
authors with profiles
JOHN KIRKWOOD